aTyr Pharma
James Cai possesses extensive experience in the pharmaceutical industry, currently serving as VP of Clinical Development at aTyr Pharma. Prior roles include VP of R&D China at AstraZeneca from 2004 to 2008, Corp Affairs Director at MSD China from 1998 to 2004, and Medical Director at Pfizer from September 1995 to December 1998. This diverse background highlights a strong foundation in clinical development, research, and corporate affairs.
aTyr Pharma
aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways.